Siglec-9 antibodies (Palleon Pharma)

N/A

Report date: 2025/01/26 16:58:17

Base Information

Drug NameSiglec-9 antibodies (Palleon Pharma)

Drug Alias NameSiglec-9 antibodies (University of Dundee)siglec-9 checkpoint inhibitor (Palleon Pharma)siglec-9 checkpoint inhibitor (University of Dundee)

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody

Mechanisms of ActionSialic acid-binding Ig-like lectin 9 inhibitors

TargetsSialic acid-binding Ig-like lectin 9

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesUniversity Of Dundee

China Registration ClassN/A

Develop Information

Active CompaniesPalleon Pharmaceuticals Inc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A